UBS Group AG Sells 13,766 Shares of Nutex Health Inc. $NUTX

UBS Group AG lessened its stake in shares of Nutex Health Inc. (NASDAQ:NUTX) by 20.0% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 55,025 shares of the company’s stock after selling 13,766 shares during the period. UBS Group AG’s holdings in Nutex Health were worth $9,058,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of NUTX. State of Alaska Department of Revenue bought a new stake in Nutex Health during the third quarter worth about $30,000. BNP Paribas Financial Markets raised its holdings in Nutex Health by 966.7% during the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock worth $40,000 after acquiring an additional 290 shares in the last quarter. Bank of America Corp DE raised its holdings in Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after acquiring an additional 2,043 shares in the last quarter. Vestcor Inc bought a new stake in Nutex Health during the third quarter worth about $111,000. Finally, New York State Common Retirement Fund bought a new stake in Nutex Health during the second quarter worth about $137,000. Institutional investors own 5.32% of the company’s stock.

Analyst Ratings Changes

Several research firms recently issued reports on NUTX. Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Wall Street Zen upgraded Nutex Health from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $205.00.

Nutex Health Price Performance

Shares of NASDAQ NUTX opened at $126.30 on Monday. The business’s 50 day moving average price is $106.26 and its two-hundred day moving average price is $127.83. The company has a market cap of $868.94 million, a PE ratio of 9.76 and a beta of 0.25. The company has a quick ratio of 3.12, a current ratio of 3.14 and a debt-to-equity ratio of 0.66. Nutex Health Inc. has a twelve month low of $77.21 and a twelve month high of $193.07.

Nutex Health (NASDAQ:NUTX) last announced its quarterly earnings results on Thursday, April 30th. The company reported $6.52 earnings per share for the quarter, topping analysts’ consensus estimates of $3.99 by $2.53. The firm had revenue of $216.49 million for the quarter, compared to the consensus estimate of $227.80 million. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.